Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 21 September 2017
Name of applicant:
Benchmark Holdings plc
Name of scheme:
The Enterprise Management Incentive (EMI) scheme and CSOP scheme
Period of return:
From:
21 March 2017
To:
21 September 2017
Balance of unallotted securities under scheme(s) from previous return:
EMI scheme - 412,000
CSOP scheme - 754,550
Total - 1,166,550
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
EMI scheme - 0
CSOP scheme - 0
Total - 0
Less:Number of securitiesissued/allotted under scheme(s) during period (see LR3.5.7G):
EMI scheme - 117,000
CSOP scheme - 866
Total - 117,866
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
EMI scheme - 295,000
CSOP scheme - 753,684
Total - 1,048,684
Name of contact:
Athene Blakeman, Company Secretary
Telephone number of contact:
44 (0) 330 313 0522
This information is provided by RNS
The company news service from the London Stock Exchange
END
Benchmark Holdings plc published this content on 21 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 September 2017 08:54:06 UTC.
Original documenthttp://tools.euroland.com/tools/Pressreleases/GetPressRelease/?ID=3379815&lang=en-GB&companycode=uk-bmk&v=uk-bmk_new
Public permalinkhttp://www.publicnow.com/view/EBE69ED0C5306F74712865A76A48E0EFC176C381
Benchmark Holdings plc is a United Kingdom-based aquaculture biotechnology company. The Company is focused on providing specialized mission-critical solutions in three complementary areas: genetics, health and advanced nutrition. The Companyâs segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with production facilities to provide a range of genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics, and sea lice treatment solutions.